UncategorizedAdvantage lands NIA funding to advance Alzheimer’s drug Empower Meds / September 29, 2025
UncategorizedAdVantage Therapeutics wins $2.5M NIH grant to advance Alzheimer’s drug – Longevity.Technology Empower Meds / September 29, 2025
UncategorizedSunrise raises $29M to expand Dreem Health and launch U.S. sleep clinic network – Longevity.Technology Empower Meds / September 29, 2025
UncategorizedGenSight raises nearly €3.7 million via share and warrant issue – Longevity.Technology Empower Meds / September 29, 2025
UncategorizedFractyl Health reports Revita sustains weight loss after GLP-1 therapy ends – Longevity.Technology Empower Meds / September 29, 2025
UncategorizedSky Labs launches CART BP, a cuffless ring-type blood pressure monitor – Longevity.Technology Empower Meds / September 29, 2025
UncategorizedL-Nutra and Parsley Health partner to deliver nutrition-based metabolic care – Longevity.Technology Empower Meds / September 29, 2025
UncategorizedClene presents data showing CNM-Au8 boosts brain energy in MS patients – Longevity.Technology Empower Meds / September 29, 2025
UncategorizedAbbVie seeks FDA approval for tavapadon to treat Parkinson’s – Longevity.Technology Empower Meds / September 29, 2025
